QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (148) Citing Articles via Google Scholar Google Scholar Articles by Middleton, F. A. Articles by Levitt, P. Search for Related Content PubMed PubMed Citation Articles by Middleton, F. A. Articles by Levitt, P.

 Previous Article  |  Next Article 

The Journal of Neuroscience, April 1, 2002, 22(7):2718-2729

Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia

Frank A. Middleton¹, Karoly Mirnics^{1, 2, 4}, Joseph N. Pierri², David A. Lewis^{2, 3}, and Pat Levitt^{1, 4}

Departments of ¹ Neurobiology, ² Psychiatry, ³ Neuroscience, and ⁴ PittArray, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261

Dysfunction of the dorsal prefrontal cortex (PFC) in schizophrenia may be associated with alterations in the regulation of brain metabolism. To determine whether abnormal expression of genes encoding proteins involved in cellular metabolism contributes to this dysfunction, we used cDNA microarrays to perform gene expression profiling of all major metabolic pathways in postmortem samples of PFC area 9 from 10 subjects with schizophrenia and 10 matched control subjects. Genes comprising 71 metabolic pathways were assessed in each pair, and only five pathways showed consistent changes (decreases) in subjects with schizophrenia. Reductions in expression were identified for genes involved in the regulation of ornithine and polyamine metabolism, the mitochondrial malate shuttle system, the transcarboxylic acid cycle, aspartate and alanine metabolism, and ubiquitin metabolism. Interestingly, although most of the metabolic genes that were consistently decreased across subjects with schizophrenia were not similarly decreased in haloperidol-treated monkeys, the transcript encoding the cytosolic form of malate dehydrogenase displayed prominent drug-associated increases in expression compared with untreated animals. These molecular analyses implicate a highly specific pattern of metabolic alterations in the PFC of subjects with schizophrenia and raise the possibility that antipsychotic medications may exert a therapeutic effect, in part, by normalizing some of these changes.

Key words: microarray; neuroleptic; haloperidol; malate; ubiquitin; ornithine; polyamine; aspartate; citrate; transcarboxylic acid; mitochondria; prefrontal

---

Copyright © 2002 Society for Neuroscience  0270-6474/02/2272718-12$05.00/0

This article has been cited by other articles:

				N. J. Bray Gene Expression in the Etiology of Schizophrenia Schizophr Bull, May 1, 2008; 34(3): 412 - 418. [Abstract] [Full Text] [PDF]

				M. J. Rossner, J. Hirrlinger, S. P. Wichert, C. Boehm, D. Newrzella, H. Hiemisch, G. Eisenhardt, C. Stuenkel, O. von Ahsen, and K.-A. Nave Global Transcriptome Analysis of Genetically Identified Neurons in the Adult Cortex J. Neurosci., September 27, 2006; 26(39): 9956 - 9966. [Abstract] [Full Text] [PDF]

				K. Iwamoto and T. Kato Gene Expression Profiling in Schizophrenia and Related Mental Disorders Neuroscientist, August 1, 2006; 12(4): 349 - 361. [Abstract] [PDF]

				S. Akbarian, M. G. Ruehl, E. Bliven, L. A. Luiz, A. C. Peranelli, S. P. Baker, R. C. Roberts, W. E. Bunney Jr, R. C. Conley, E. G. Jones, et al. Chromatin Alterations Associated With Down-regulated Metabolic Gene Expression in the Prefrontal Cortex of Subjects With Schizophrenia Arch Gen Psychiatry, August 1, 2005; 62(8): 829 - 840. [Abstract] [Full Text] [PDF]

				A. Kato, N. Rouach, R. A. Nicoll, and D. S. Bredt Activity-dependent NMDA receptor degradation mediated by retrotranslocation and ubiquitination PNAS, April 12, 2005; 102(15): 5600 - 5605. [Abstract] [Full Text] [PDF]

				K. Iwamoto, M. Bundo, and T. Kato Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis Hum. Mol. Genet., January 15, 2005; 14(2): 241 - 253. [Abstract] [Full Text] [PDF]

				T. Hashimoto, S. E. Bergen, Q. L. Nguyen, B. Xu, L. M. Monteggia, J. N. Pierri, Z. Sun, A. R. Sampson, and D. A. Lewis Relationship of Brain-Derived Neurotrophic Factor and Its Receptor TrkB to Altered Inhibitory Prefrontal Circuitry in Schizophrenia J. Neurosci., January 12, 2005; 25(2): 372 - 383. [Abstract] [Full Text] [PDF]

				Y. Komatsu, A. Watakabe, T. Hashikawa, S. Tochitani, and T. Yamamori Retinol-binding Protein Gene is Highly Expressed in Higher-order Association Areas of the Primate Neocortex Cereb Cortex, January 1, 2005; 15(1): 96 - 108. [Abstract] [Full Text] [PDF]

				J. Zhang, A. Moseley, A. G. Jegga, A. Gupta, D. P. Witte, M. Sartor, M. Medvedovic, S. S. Williams, C. Ley-Ebert, L. M. Coolen, et al. Neural system-enriched gene expression: relationship to biological pathways and neurological diseases Physiol Genomics, July 8, 2004; 18(2): 167 - 183. [Abstract] [Full Text] [PDF]

				N. Nishioka and S. E. Arnold Evidence for Oxidative DNA Damage in the Hippocampus of Elderly Patients With Chronic Schizophrenia Am J Geriatr Psychiatry, April 1, 2004; 12(2): 167 - 175. [Abstract] [Full Text] [PDF]

				J. Z. Li, M. P. Vawter, D. M. Walsh, H. Tomita, S. J. Evans, P. V. Choudary, J. F. Lopez, A. Avelar, V. Shokoohi, T. Chung, et al. Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions Hum. Mol. Genet., March 15, 2004; 13(6): 609 - 616. [Abstract] [Full Text] [PDF]

				C. Konradi, M. Eaton, M. L. MacDonald, J. Walsh, F. M. Benes, and S. Heckers Molecular Evidence for Mitochondrial Dysfunction in Bipolar Disorder Arch Gen Psychiatry, March 1, 2004; 61(3): 300 - 308. [Abstract] [Full Text] [PDF]

				N. Mah, A. Thelin, T. Lu, S. Nikolaus, T. Kuhbacher, Y. Gurbuz, H. Eickhoff, G. Kloppel, H. Lehrach, B. Mellgard, et al. A comparison of oligonucleotide and cDNA-based microarray systems Physiol Genomics, February 13, 2004; 16(3): 361 - 370. [Abstract] [Full Text] [PDF]

				T. Hashimoto, D. W. Volk, S. M. Eggan, K. Mirnics, J. N. Pierri, Z. Sun, A. R. Sampson, and D. A. Lewis Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia J. Neurosci., July 16, 2003; 23(15): 6315 - 6326. [Abstract] [Full Text] [PDF]

				W. E. Bunney, B. G. Bunney, M. P. Vawter, H. Tomita, J. Li, S. J. Evans, P. V. Choudary, R. M. Myers, E. G. Jones, S. J. Watson, et al. Microarray Technology: A Review of New Strategies to Discover Candidate Vulnerability Genes in Psychiatric Disorders Am J Psychiatry, April 1, 2003; 160(4): 657 - 666. [Abstract] [Full Text] [PDF]

				F. M. Benes, J. Walsh, S. Bhattacharyya, A. Sheth, and S. Berretta DNA Fragmentation Decreased in Schizophrenia but Not Bipolar Disorder Arch Gen Psychiatry, April 1, 2003; 60(4): 359 - 364. [Abstract] [Full Text] [PDF]

				R. C. Elliott, M. F. Miles, and D. H. Lowenstein Overlapping Microarray Profiles of Dentate Gyrus Gene Expression during Development- and Epilepsy-Associated Neurogenesis and Axon Outgrowth J. Neurosci., March 15, 2003; 23(6): 2218 - 2227. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help